Journal
CURRENT OSTEOPOROSIS REPORTS
Volume 12, Issue 3, Pages 263-271Publisher
SPRINGER
DOI: 10.1007/s11914-014-0219-y
Keywords
Paget's disease of bone; Osteitis deformans; Osteoclast; Genetic; SQSTM1; RIN3; Optineurin; RANK; RANKL; Osteoprotegerin; DC-STAMP; TM7SF4; Macrophage colony stimulating factor; M-CSF; CSF1; Bone resorption; Fracture; NF kappa B; Osteosarcoma
Categories
Funding
- Medical Research Council [G0701625] Funding Source: researchfish
- Versus Arthritis [19799] Funding Source: researchfish
- MRC [G0701625] Funding Source: UKRI
- Arthritis Research UK [19799] Funding Source: Medline
- Medical Research Council [G0701625] Funding Source: Medline
- Versus Arthritis [19799] Funding Source: Medline
Ask authors/readers for more resources
Paget's disease of bone (PDB) is a common condition, which is characterised by focal areas of increased and disorganized bone remodeling. Genetic factors play an important role in the disease. In some cases, Paget's disease is inherited in an autosomal dominant manner and the most common cause for this is a mutation in the SQSTM1 gene. Other familial cases have been linked to the OPTN locus on Chromosome 10p13 and still other variants have been identified by genome wide association studies that lie within or close to genes that play roles in osteoclast differentiation and function. Mutations in TNFRSF11A, TNFRSF11B and VCP have been identified in rare syndromes with PDB-like features. These advances have improved understanding of bone biology and the causes of PDB. The identification of genetic markers for PDB also raises the prospect that genetic profiling could identify patients at high risk of developing complications, permitting enhanced surveillance and early therapeutic intervention.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available